{"id":42961,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/wafer-supply-agreement-amendment-no-1-advanced-micro-devices.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"wafer-supply-agreement-amendment-no-1-advanced-micro-devices","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/operations\/wafer-supply-agreement-amendment-no-1-advanced-micro-devices.html","title":{"rendered":"Wafer Supply Agreement Amendment No. 1 &#8211; Advanced Micro Devices"},"content":{"rendered":"<p align=\"center\"><strong>WAFER SUPPLY AGREEMENT AMENDMENT NO. 1 <\/strong><\/p>\n<p>This First Amendment to the WAFER SUPPLY AGREEMENT (this<br \/>\n&#8220;<strong>Amendment<\/strong>&#8220;), dated as of March 29, 2011, amends that certain<br \/>\nWafer Supply Agreement, dated March 2, 2009, (the &#8220;<strong>Agreement<\/strong>&#8220;)<br \/>\nby and among (i) Advanced Micro Devices, Inc., a Delaware corporation<br \/>\n(&#8220;<strong>AMD<\/strong>&#8220;); (ii) with respect to all of the provisions in the<br \/>\nAgreement other than those in Sections 5.5(a), 6.2 and 7.3(a) of the Agreement<br \/>\nand the related provisions of the Agreement in connection with sales activities<br \/>\nonly (though without limiting FoundryCo&#8217;s guarantee obligations pursuant to<br \/>\nSection 15.7 of the Agreement), GLOBALFOUNDRIES Inc., an exempted company<br \/>\nincorporated under the laws of the Cayman Islands<br \/>\n(&#8220;<strong>FoundryCo<\/strong>&#8220;), on behalf of itself and its direct and indirect<br \/>\nwholly-owned subsidiaries, including all FoundryCo Sales Entities and FoundryCo<br \/>\nManufacturing Entities, as further set forth in the Agreement; (iii) subject to<br \/>\nFoundryCo&#8217;s guarantee obligations pursuant to Section 15.7 of the Agreement,<br \/>\nGLOBALFOUNDRIES U.S. Inc., a Delaware corporation and a wholly owned subsidiary<br \/>\nof FoundryCo (&#8220;<strong>USOpCo<\/strong>&#8220;), which is a party to the Agreement<br \/>\nsolely with respect to Sections 5.5(a), 6.2 and 7.3(a) of the Agreement and the<br \/>\nrelated provisions of the Agreement in connection with USOpCo&#8217;s sales<br \/>\nactivities; and (iv) subject to FoundryCo&#8217;s guarantee obligations pursuant to<br \/>\nSection 15.7 of the Agreement, GLOBALFOUNDRIES Singapore Pte. Ltd., a private<br \/>\nlimited Singapore company and a wholly owned subsidiary of FoundryCo<br \/>\n(&#8220;<strong>GFS<\/strong>&#8220;), which, by executing this Amendment, is becoming a<br \/>\nparty to the Agreement solely with respect to Sections 5.5(a), 6.2 and 7.3(a) of<br \/>\nthe Agreement and the related provisions of the Agreement in connection with<br \/>\nGFS&#8217; sales activities.<\/p>\n<p>WHEREAS, the parties wish to modify certain pricing and other terms of the<br \/>\nWafer Supply Agreement with respect to MPU Products to be delivered by FoundryCo<br \/>\nto AMD during 2011 as well as regarding certain payments to be made by AMD in<br \/>\n2012 relating to MPU Products; and<\/p>\n<p>WHEREAS, the parties wish to permanently amend the Agreement with respect to<br \/>\nGPU Products, Chipset Products (as defined below) and FoundryCo Sales Entities;\n<\/p>\n<p>NOW, THEREFORE, in consideration of the promises and the mutual agreements<br \/>\nand covenants hereinafter set forth, and intending to be legally bound, the<br \/>\nparties hereby agree as follows:<\/p>\n<p><strong>1. <\/strong>AMENDMENTS RELATED TO GPU PRODUCTS<\/p>\n<p>1.1 <u>Section 1.52.1<\/u><\/p>\n<p>The following defined term shall be added to the Agreement immediately<br \/>\nfollowing Section 1.52 of the Agreement:<\/p>\n<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>1.52.1 <strong><em>&#8220;GPU Plan of Record&#8221;<\/em><\/strong> shall mean a long-range<br \/>\nplanning document prepared by AMD, as amended from time to time as provided in<br \/>\nSection 2.1(c), that outlines AMD&#8217;s planned tape-out and production schedule for<br \/>\neach GPU Product, and identifying each GPU Product Family.<\/p>\n<p>1.2 <u>Section 1.53.1<\/u><\/p>\n<p>The following defined term shall be added to the Agreement immediately<br \/>\nfollowing Section 1.53 of the Agreement:<\/p>\n<p>1.53.1 &#8220;<strong><em>GPU Product Family<\/em><\/strong>&#8221; means any group of GPU<br \/>\nProducts that are developed by AMD as part of a single product marketing and<br \/>\ndesign cycle and that are generally differentiated by AMD from other GPU<br \/>\nProducts based on performance, power and cost, as identified by AMD in the GPU<br \/>\nPlan of Record.<\/p>\n<p>1.53.2 &#8220;<strong><em>GPU Product Technology Readiness Condition&#8221;<\/em><\/strong><br \/>\nmeans, with respect to each GPU Product, a condition that shall be deemed to be<br \/>\nsatisfied if and when FoundryCo has achieved, on or before the GPU Product<br \/>\nTechnology Readiness Date, the passage of the certain [****] criteria which<br \/>\ndefine a set of important parameters related to [****] milestones (the<br \/>\n&#8220;<strong>Critical Parameters<\/strong>&#8220;). The definition of Critical Parameters<br \/>\nfor each GPU Product will be mutually agreed in good faith by AMD and FoundryCo.<br \/>\nIn the event that AMD shall change the GPU Plan of Record, the parties agree to<br \/>\nmeet in good faith to determine whether such change requires any corresponding<br \/>\nchanges to the Critical Parameters. FoundryCo and AMD will evaluate the<br \/>\nachievement of the Critical Parameters in accordance with industry standard<br \/>\npractice, and based on such evaluation will jointly and in good faith determine<br \/>\nwhether this condition is substantially or sufficiently satisfied for the<br \/>\npurposes of Section 2.1(c)(ii)(A), (B) and (C).<\/p>\n<p>1.53.3 &#8220;<strong><em>GPU Product Technology Readiness Date&#8221;<\/em><\/strong><br \/>\nmeans, with respect to each GPU Product, a date to be mutually agreed in good<br \/>\nfaith by AMD and FoundryCo as the earliest date at which the parties will<br \/>\ndetermine whether the GPU Product Technology Readiness Condition has been<br \/>\nsatisfied. Specifically, for the purposes of the GPU Volume Ramp Products, the<br \/>\nGPU Product Technology Readiness Date shall be [****], provided that the parties<br \/>\nwill jointly evaluate by [****] whether or not FoundryCo will satisfy the GPU<br \/>\nProduct Technology Readiness Condition for the [****] GPU Product Family by<br \/>\n[****], and if necessary, will discuss and implement an action plan that enables<br \/>\nAMD to award GPU Volume Ramp Products to FoundryCo.<\/p>\n<p>1.3 <u>Section 2.1(c)<\/u><\/p>\n<p>Section 2.1(c) of the Agreement shall be amended and restated in its entirety<br \/>\nto read as follows:<\/p>\n<p><strong>(c)<\/strong> <strong>GPU Products.<\/strong><\/p>\n<p>i. AMD and FoundryCo each commits to, and the parties agree to work together<br \/>\nto, [****] manufacture GPU Products via a high volume bulk process at the<br \/>\n[****]nm Process Node and at all future smaller Process Nodes, with<br \/>\nSpecifications to be agreed<\/p>\n<\/p>\n<p align=\"center\">2<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>upon in advance by the parties in writing. AMD&#8217;s obligations and commitments<br \/>\nset forth below under this Section 2.1(c) are subject to the satisfaction by<br \/>\nFoundryCo of the GPU Product Technology Readiness Condition applicable to any<br \/>\ngiven GPU Product, on or before the GPU Product Technology Readiness Date<br \/>\napplicable to such GPU Product. FoundryCo acknowledges and agrees that all GPU<br \/>\nProduct commitments of AMD are subject to the [****] process set forth in<br \/>\nExhibit B, which includes without limitation an analysis of FoundryCo&#8217;s ability<br \/>\nto manufacture any such GPU Products at [****].<\/p>\n<p>ii. In order to assist FoundryCo to establish FoundryCo&#8217;s ability to meet<br \/>\nAMD&#8217;s demand for GPU Products, AMD commits (subject to the condition set forth<br \/>\nin Section 2.1(c)(i)) to have FoundryCo manufacture: [****] (collectively, these<br \/>\n[****] GPU Products are the &#8220;<strong>GPU Volume Ramp Products<\/strong>&#8220;). AMD<br \/>\nshall also (x) supply to FoundryCo or to [****], or (y) provide to FoundryCo a<br \/>\nversion of [****] or [****] in a [****] architecture so that FoundryCo can<br \/>\n[****], in each case as the parties mutually agree is suitable [****] to support<br \/>\nFoundryCo&#8217;s manufacturing readiness for the [****] GPU Product Family.<\/p>\n<p>A. In the event that FoundryCo has [****] achieved [****] of the Critical<br \/>\nParameters by the GPU Product Technology Readiness Date for the GPU Volume Ramp<br \/>\nProducts, then AMD shall [****] the GPU Volume Ramp Products at FoundryCo and<br \/>\nshall [****] of AMD&#8217;s requirements for the GPU Volume Ramp Products from<br \/>\nFoundryCo.<\/p>\n<p>B. In the event that FoundryCo has achieved [****] of the Critical Parameters<br \/>\nby the GPU Product Technology Readiness Date for the GPU Volume Ramp Products,<br \/>\n[****] has met [****] Critical Parameters to be [****] to [****] the GPU Product<br \/>\nTechnology Readiness Condition and [****] the [****] for each GPU [****]<br \/>\nProduct, then FoundryCo and AMD shall identify and mutually agree on [****]<br \/>\nactions (the &#8220;[****]<strong> Actions&#8221;) <\/strong>to be [****] in the shortest<br \/>\nperiod of time (such time period to be agreed upon in advance) for each GPU<br \/>\nProduct (the &#8220;[****]<strong> Time<\/strong>&#8220;).<\/p>\n<p>(a) If FoundryCo completes [****] Actions within the [****] Time, then AMD<br \/>\nshall [****] the GPU Volume Ramp Products at FoundryCo and shall [****] of AMD&#8217;s<br \/>\nrequirements for the GPU Volume Ramp Products from FoundryCo.<\/p>\n<p>(b) If FoundryCo completes [****] Actions after the [****] Time [****] before<br \/>\n[****], then AMD shall use commercially reasonable efforts to [****] GPU Volume<br \/>\nRamp Products at FoundryCo and to [****] of its requirements for the GPU Volume<br \/>\nRamp Products at FoundryCo.<\/p>\n<p>C. In the event that FoundryCo [****] achieve [****] a [****] number of<br \/>\nCritical Parameters by the GPU Product Technology Readiness Date for the GPU<br \/>\nVolume Ramp Products to be [****] to [****] the [****] for any such Product,<br \/>\nthen FoundryCo shall not be [****] in accordance with the procedures set forth<br \/>\nin Exhibit B in accordance with Section 2.1(c)(i), and AMD may [****] for the<br \/>\nGPU Volume Ramp Products.<\/p>\n<\/p>\n<p align=\"center\">3<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>D. In order to implement these commitments with respect to the GPU Volume<br \/>\nRamp Products, the parties further agree as follows:<\/p>\n<p>(a) AMD may continue to work with other foundry partners to design and<br \/>\nprepare to manufacture GPU Products from the [****] GPU Product Family, as long<br \/>\nas such design efforts do not divert design and engineering resources from the<br \/>\njoint development effort described in the following paragraph.<\/p>\n<p>(b) Immediately upon completion of the design activity for the [****]<br \/>\ncurrently code-named [****] which is currently scheduled to be completed [****],<br \/>\nAMD and FoundryCo shall each commit [****] full-time-equivalent, highly<br \/>\nqualified and experienced design engineers (including engineers currently<br \/>\ncommitted to the [****] design efforts, or other engineers mutually acceptable<br \/>\nto the other party), together with their associated support resources, to a<br \/>\njoint AMD\/FoundryCo effort to complete, on or before [****], the full suite of<br \/>\nIntellectual Property required for [****] and [****] targeted to be manufactured<br \/>\nat FoundryCo using FoundryCo&#8217;s [****]nm technology.<\/p>\n<p>(c) The process-design interaction for the [****] GPU Product Family will be<br \/>\nvalidated using [****]; provided that any additional Intellectual Property<br \/>\nspecific to the GPU Volume Ramp Products that is required to be silicon verified<br \/>\nmay be verified using [****], with the cost to be [****].<\/p>\n<p>iii. AMD agrees that, starting with the GPU Product Family currently<br \/>\ncode-named [****] AMD will purchase at least [****] percent ([****]%) of its<br \/>\nrequirements for GPU Products measured on a [****] basis (such minimum<br \/>\npercentage, the &#8220;<strong>GPU Minimum Percentage<\/strong>&#8220;) for the remaining<br \/>\nduration of this Agreement. In order to achieve the GPU Minimum Percentage, AMD<br \/>\ncommits (subject to the condition set forth in Section 2.1(c)(i)) to have<br \/>\nFoundryCo manufacture at least [****] GPU Products from each of the [****] and<br \/>\n[****] GPU Product Families.<\/p>\n<p>iv. For the [****] and [****] GPU Product Families, FoundryCo and AMD shall<br \/>\ndetermine whether FoundryCo has [****],[****] or [****] the GPU Product<br \/>\nTechnology Readiness Condition for each GPU Product in the same manner set forth<br \/>\nin Sections 2.1(c)(ii)(A), (B) and (C), with purchase commitments determined<br \/>\naccording to Section 2.1(c)(iii). This determination shall be made on a<br \/>\nProduct-by-Product basis and shall not affect such determination for any other<br \/>\nGPU Product or change the GPU Minimum Percentage.<\/p>\n<p>v. If for an applicable quarter it is determined that AMD has not (A) placed<br \/>\norders for manufacture by FoundryCo of the GPU Volume Ramp Products or the GPU<br \/>\nMinimum Percentage of GPU Products starting with the [****] GPU Product Family,<br \/>\nor (B) complied with any other requirements as set forth herein to enable<br \/>\nFoundryCo the opportunity to manufacture the GPU Minimum Percentage throughout<br \/>\nthe entire duration of this Agreement, the parties agree to meet, discuss and<br \/>\nimplement a mutually acceptable corrective action plan to address such<br \/>\nnon-compliance and to enable FoundryCo to manufacture higher volumes of the GPU<br \/>\nProducts in the following quarters.<\/p>\n<\/p>\n<p align=\"center\">4<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>vi. <u>Cooperation and Partnership on GPU Products<\/u>. In order (A) to<br \/>\nensure the coordination of FoundryCo&#8217;s technology roadmap and development and<br \/>\nimplementation of necessary process technology in a timely manner to intersect<br \/>\nAMD&#8217;s GPU Product roadmap on a schedule that will enable FoundryCo to establish<br \/>\nQualified Processes for GPU Products and satisfy the GPU Product Technology<br \/>\nReadiness Condition for each GPU Product by the GPU Product Technology Readiness<br \/>\nDate for such GPU Product, as provided in this Section 2.1(c), (B) to enable<br \/>\nFoundryCo to meet AMD&#8217;s requirements to manufacture GPU Products so that AMD<br \/>\nwill purchase the GPU Volume Ramp Products as well as purchase the GPU Minimum<br \/>\nPercentage as anticipated in subsection (iii) above, and (C) to allow FoundryCo<br \/>\nto compete for incremental GPU Products above the GPU Minimum Percentage, AMD<br \/>\nand FoundryCo each commits to take the following steps with respect to GPU<br \/>\nProducts, with the intent of the parties to bring the same rigor and level of<br \/>\ncollaboration to the GPU migration process that currently exists between AMD and<br \/>\nFoundryCo in their partnership to develop and qualify processes for MPU<br \/>\nProducts:<\/p>\n<p>A. AMD shall share with FoundryCo on a timely basis AMD&#8217;s GPU Product roadmap<br \/>\nschedules, detailed GPU Product requirements, detailed technology needs,<br \/>\nforecasts of volume requirements for all GPU Products by quarter, and all other<br \/>\npertinent information that AMD has that is related to AMD&#8217;s product requirements<br \/>\nand technology needs for the applicable GPU Products, including information<br \/>\nregarding device targets, product performance requirements, and known process<br \/>\ntechnology requirements (collectively, the &#8220;<strong>GPU Product Roadmap<br \/>\nInformation<\/strong>&#8220;). AMD agrees to deliver to FoundryCo the GPU Product<br \/>\nRoadmap Information, together with all supporting information reasonably<br \/>\nrequested by FoundryCo, as early as practicable to ensure that FoundryCo has<br \/>\ntime to develop and qualify the processes required for FoundryCo to manufacture<br \/>\nGPU Products for AMD in accordance with such roadmaps and this Section 2.1(c).<br \/>\nAMD agrees to regularly update FoundryCo with additional GPU Product Roadmap<br \/>\nInformation consistent with the technology review and update process set forth<br \/>\nin Schedule B to this Amendment. [****] In the event that, following the [****]<br \/>\ndescribed in Exhibit B, AMD selects a foundry partner other than FoundryCo to<br \/>\nmanufacture a particular GPU Product, AMD shall [****] GPU Product Roadmap<br \/>\nInformation on such GPU Product [****] such time that AMD has taped out such GPU<br \/>\nProduct at such other AMD foundry partner. In addition, AMD shall continuously<br \/>\n[****] updated quarterly volume forecasts for each GPU Product [****] for as<br \/>\nlong as AMD is ordering such GPU Product from [****]. For the avoidance of<br \/>\ndoubt, AMD shall be required to [****] the GPU Product Roadmap Information,<br \/>\nbeginning on the date hereof, for all GPU Products, regardless of whether or not<br \/>\nFoundryCo has qualified a process to produce such products and regardless of<br \/>\nwhether AMD has committed or intends to commit the production of all or some of<br \/>\nits requirements for such GPU Products to one or more foundries other than<br \/>\nFoundryCo.<\/p>\n<p>B. AMD shall establish an annual GPU Plan of Record that includes identified<br \/>\nGPU Products with quarterly wafer volumes sufficient to first achieve and then<br \/>\nmaintain the GPU Minimum Percentage as set forth above. FoundryCo acknowledges<br \/>\nand agrees that AMD has sole discretion regarding the GPU Products it designs<br \/>\nand decides to have manufactured, and as a result, subject to the obligations<br \/>\nset forth in this Section 2.1, including<\/p>\n<\/p>\n<p align=\"center\">5<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>meeting the GPU Minimum Percentage as set forth above, AMD may change the GPU<br \/>\nPlan of Record in response to changes in the GPU Product market or in AMD&#8217;s<br \/>\nposition in that market.<\/p>\n<p>C. AMD and FoundryCo will establish separate GPU QTR\/QBR and supporting<br \/>\nmeetings on a regular cadence (basis) to track the parties&#8217; product and process<br \/>\ntechnology requirements and progress in order to achieve the GPU Product<br \/>\nmanufacturing and purchase commitments set forth in this Section 2.1(c) with the<br \/>\nsame rigor and level of collaboration as the parties maintain in the development<br \/>\nand manufacture of MPU Products. Specifically, AMD and FoundryCo shall initially<br \/>\nuse such processes to refine the GPU Plan of Record with the goal of<br \/>\nestablishing FoundryCo&#8217;s ability to manufacture GPU Products and meeting the GPU<br \/>\nMinimum Percentage as soon as practicable.<\/p>\n<p>D. The parties will develop formalized executive level oversight of the<br \/>\ncommitments set out in this Section 2.1(c), including a designated executive at<br \/>\neach of AMD and FoundryCo to drive and track progress towards achieving the GPU<br \/>\nProduct manufacturing targets set forth in the GPU Plan of Record. In addition<br \/>\nto the executive level oversight, each party shall document a process with<br \/>\nsenior management accountability to align mid-level management execution of the<br \/>\ncommitments set forth herein and coordinate communications between such<br \/>\nmid-level management at each party. This alignment process shall include<br \/>\nparticipation by non-operational executives of FoundryCo and AMD.<\/p>\n<p>vii. For each GPU Product (including the first-tape out of such GPU Product),<br \/>\nFoundryCo shall have a [****] in accordance with the process set forth in<br \/>\nExhibit B to manufacture such GPU Product. For the avoidance of doubt, the<br \/>\nparties agree that FoundryCo shall have such [****] in accordance with the<br \/>\nprocess set forth in Exhibit B with respect to each GPU Product (whether or not<br \/>\nsuch GPU Product is the first GPU Product) at each [****] of [****].<\/p>\n<p>viii. AMD agrees not to sell, transfer or otherwise dispose of all or<br \/>\nsubstantially all of its or its Subsidiaries&#8217; assets related to GPU Products and<br \/>\nrelated technology (including the equity interests of ATI Technologies ULC or<br \/>\nits other subsidiaries that own such assets) to any person (other than to AMD or<br \/>\nanother of its Subsidiaries) without the consent of FoundryCo, unless the<br \/>\ntransferee (A) agrees to be bound by the provisions of this Agreement with<br \/>\nrespect to GPU Products, including FoundryCo&#8217;s [****] with respect to each GPU<br \/>\nProduct and the commitments to purchase the GPU Volume Ramp Products as set<br \/>\nforth in this Section 2.1(c), and (B) agrees to purchase, on an annual basis,<br \/>\nGPU Products in an amount at least equal to the GPU Minimum Percentage.<\/p>\n<\/p>\n<p align=\"center\">6<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p><strong>2. <\/strong>AMENDMENTS RELATED TO CHIPSET PRODUCTS<\/p>\n<p>2.1 <u>Section 1.29.1<\/u><\/p>\n<p>The following defined term shall be added to the Agreement immediately<br \/>\nfollowing Section 1.29:<\/p>\n<p>1.29.1 <em>&#8220;<\/em><strong><em>Chipset Products&#8221;<\/em><\/strong> shall mean one<br \/>\nor more integrated circuits marketed and sold by AMD as a separate product, that<br \/>\nare manufactured at the [****]nm and any smaller Process Node, and that are<br \/>\ndesigned to mediate the flow of data between the central processing unit and<br \/>\nperipheral devices utilizing a PCI, PCIe, universal serial bus (USB), Serial ATA<br \/>\n(SATA), low pin count (LPC), Integrated Drive Electronics (IDE), Azalia HD Audio<br \/>\n(AZ), Serial Peripheral Interface (SPI), Secure Digital Input Output (SDIO) or<br \/>\nsimilar bus.<\/p>\n<p>2.2 <u>Section 2.1(f)<\/u><\/p>\n<p>Section 2.1 of the Agreement shall be amended by the addition of the<br \/>\nfollowing language as a new sub-Section 2.1(f), which shall read in its entirety<br \/>\nas follows:<\/p>\n<p><strong>(f) Chipset Volumes <\/strong><\/p>\n<p>i. Each party commits to, and the parties agree to work together to,<br \/>\nestablish FoundryCo&#8217;s ability to manufacture Chipset Products via a [****]nm<br \/>\nbulk silicon process at the [****]nm Process Node and at all future smaller<br \/>\nProcess Nodes for which AMD may purchase Chipset Products, with Specifications<br \/>\nto be agreed upon in advance by the parties in writing.<\/p>\n<p>ii. AMD agrees that, beginning with the [****] family of Chipset Products<br \/>\n(or, subject to the last clause of this paragraph (ii), any successor or<br \/>\nreplacement family of Chipset Products at the [****]nm and any smaller Process<br \/>\nNode)<sup>1<\/sup>, and continuing for the entire duration of this Agreement, AMD<br \/>\nwill purchase [****]% of its requirements (including the requirements of its<br \/>\nSubsidiaries) for any new Chipset Products from FoundryCo; provided, however,<br \/>\nthat if AMD purchases a company or assets from a company that has at the time of<br \/>\nacquisition, Chipset Products in production or that have already taped out for<br \/>\nmanufacture at a third party foundry, such acquired Chipset Products will not be<br \/>\nsubject to this Section 2.1(f).<\/p>\n<p>2.3 <u>Section 7.1(c-2)<\/u><\/p>\n<p>Section 7.1 of the Agreement shall be amended by the addition of the<br \/>\nfollowing language as a new sub-Section 7.1(c-2) (to be inserted between<br \/>\nexisting sub-Sections 7.1(c) and 7.1(d)), which shall read in its entirety as<br \/>\nfollows:<\/p>\n<p><sup>1<\/sup> As of the effective date of this Amendment, the [****] Chipset<br \/>\nProduct on AMD&#8217;s [****] is the one code-named [****].<\/p>\n<\/p>\n<p align=\"center\">7<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>(c-2) <u>Chipset Product Pricing<\/u>. The pricing for Chipset Products shall<br \/>\nbe based on [****]. The price for Engineering Wafers for Chipset Products shall<br \/>\nbe determined by [****].<\/p>\n<p><strong>3. <\/strong>AMENDMENTS RELATED TO MPU PRODUCT PRICING IN 2011<\/p>\n<p>3.1 <u>MPU Product Prices for 2011.<\/u><\/p>\n<p>(a) Notwithstanding Section 7.1 and Exhibit A of the Agreement, the price for<br \/>\nMPU Products delivered by FoundryCo to AMD in 2011 (including MPU Products in<br \/>\nboth [****] and [****] (as defined in Schedule D to this Amendment), and [****]<br \/>\ncontaining MPU Products (&#8220;<strong>PQUL Wafers<\/strong>&#8220;)) shall be as set forth<br \/>\nin Schedule D to this Amendment.<\/p>\n<p>(b) Payment by AMD of the purchase price set forth in Schedule D to this<br \/>\nAmendment for MPU Products delivered in 2011 shall be, with respect to such MPU<br \/>\nProducts, in lieu of the payment of (A) the price for [****] containing [****]<br \/>\nset forth in Section 1 of Exhibit A to this Agreement, and (B) the price for<br \/>\n[****] MPU Products set forth in Section 4 of Exhibit A to the Agreement.<br \/>\nPayments of the purchase prices set forth in Schedule D for MPU Products<br \/>\ndelivered in 2011, however, shall be exclusive of and shall not affect the<br \/>\nobligation of AMD to pay for [****].<\/p>\n<p>3.2 <u>2011 Additional [****] Fixed Payments.<\/u> In addition to the prices<br \/>\nset forth for purchases by AMD of MPU Products slated for delivery in 2011, AMD<br \/>\nagrees to pay FoundryCo certain additional fixed <u>[****]<\/u> payments (the<br \/>\n&#8220;<strong>2011 Additional <\/strong><u>[****]<\/u> <strong>Fixed<br \/>\nPayments<\/strong>&#8220;) as set forth in Schedule D.<\/p>\n<p>3.3 <u>Consequence of Failure to be in Commercial Production in 2011<\/u><\/p>\n<p>(a) FoundryCo shall be deemed to be in &#8220;<strong>Commercial Production in<br \/>\n2011<\/strong>&#8221; of [****] MPU Products if either one of these events has<br \/>\noccurred: (i) the achievement of the [****] milestone for the [****] (as defined<br \/>\nin Schedule A to this Amendment); or (ii) AMD has ordered [****] MPU Product<br \/>\nProduction Wafers for delivery in [****] of 2011.<\/p>\n<p>(b) In the event that FoundryCo does not enter into Commercial Production in<br \/>\n2011, then in lieu of AMD&#8217;s obligation to pay for [****] MPU Products as set<br \/>\nforth in Schedule D, FoundryCo may instead invoice any time after the [****] day<br \/>\nof [****] of 2011, and before the [****] day of the [****], AMD will pay within<br \/>\nforty-five (45) days of the invoice date, [****] Dollars ($[****]]),<br \/>\nrepresenting [****] percent ([****]%) of FoundryCo&#8217;s [****] MPU Product fixed<br \/>\ncosts. FoundryCo acknowledges that if it does not achieve Commercial Production<br \/>\nin 2011, then it will not have met the conditions to be entitled to receive the<br \/>\n2012 Additional [****] Payments (as defined below), and as a consequence the<br \/>\n2012 Additional [****] Payments will not have been earned and will not be<br \/>\npayable.<\/p>\n<\/p>\n<p align=\"center\">8<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>3.4 <u>2012 Additional [****] Payments.<\/u><\/p>\n<p>(a) Subject to the conditions set forth below, AMD will pay to FoundryCo the<br \/>\naggregate additional amount of [****] Dollars ($[****]), payable in [****]<br \/>\ninstallments of [****] Dollars ($[****]) (collectively, the &#8220;<strong>2012<br \/>\nAdditional <\/strong>[****]<strong> Payments<\/strong>&#8220;). The obligation to pay<br \/>\nthe 2012 Additional [****] Payments is contingent upon FoundryCo being in<br \/>\nCommercial Production of [****] MPU Products in 2012, even if the Yields for<br \/>\nsuch [****] MPU Products fall below the Target Yield Curve (as defined in<br \/>\nSchedule D) for such [****] MPU Products in 2012.<\/p>\n<p>(b) FoundryCo shall be deemed to be in &#8220;<strong>Commercial Production of<br \/>\n<\/strong>[****]<strong> MPU Products in 2012<\/strong>&#8221; if FoundryCo has achieved<br \/>\nCommercial Production in 2011 (as defined above), and on or after [****] fiscal<br \/>\n2012 FoundryCo continues to offer committed capacity to AMD to manufacture<br \/>\n[****] MPU Product Production Wafers for delivery in 2012.<\/p>\n<p>(c) Notwithstanding subsection 3.4(a) above, the 2012 Additional [****]<br \/>\npayments are subject to reduction in the event that FoundryCo earns any Yield<br \/>\nBonus Revenue as set forth in Section 12 of Schedule D.<\/p>\n<p>(d) Subject to the provisions of this Amendment, [****] days prior to the end<br \/>\nof [****] in 2012, FoundryCo shall invoice, and AMD shall pay on or prior to the<br \/>\nlast day of [****], the applicable 2012 Additional [****] Payment.<\/p>\n<p>3.5 <u>Reversion to Existing Pricing Model for MPU Products in 2012.<\/u> On<br \/>\nand after January 1, 2012, except as set forth in Section 3.3 above, the parties<br \/>\nwill revert to the MPU Product pricing set forth in Section 7.1(a) and Exhibit A<br \/>\nof the Agreement for all MPU Products.<\/p>\n<p>3.6 <u>Other Payment Obligations in 2011.<\/u> During 2011, except as<br \/>\nexplicitly set forth in this Amendment, the parties will continue to perform<br \/>\ntheir respective obligations under this Agreement, including forecasts, process<br \/>\nimplementation procedures, etc. The financial terms in Schedule D incorporate<br \/>\nthe payment of [****] Costs and [****] Costs under this Agreement, but will not<br \/>\nmodify any other [****] or [****] obligations of the parties under the<br \/>\nAgreement. With respect to [****] Wafer Outs containing [****]nm MPU Products<br \/>\nthat were originally ordered by AMD for delivery in [****], [****], such [****]<br \/>\nhave been or will be invoiced at prices calculated according to Section 7.1(a)<br \/>\nand Exhibit A of the Agreement, and the prices for [****] will not be modified<br \/>\nby Schedule D of this Amendment.<\/p>\n<p><strong>4.<\/strong> AMENDMENTS RELATED TO FOUNDRYCO SALES ENTITIES<\/p>\n<p>4.1 <u>Section 1.48<\/u><\/p>\n<p>Section 1.48 of the Agreement shall be amended and restated in its entirety<br \/>\nto read as follows:<\/p>\n<p>1.48 <strong><em>&#8220;FoundryCo Sales Entities&#8221;<\/em><\/strong> shall mean USOpCo,<br \/>\nGFS, and any other direct or indirect wholly-owned subsidiaries of FoundryCo to<br \/>\nwhich FoundryCo has<\/p>\n<\/p>\n<p align=\"center\">9<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>delegated the responsibility to process purchase orders from AMD and to offer<br \/>\nto sell and sell Products to AMD in accordance with this Agreement.<\/p>\n<p><strong>5.<\/strong> AMENDMENTS RELATED TO AUDIT PROVISIONS<\/p>\n<p>5.1 <u>Additional Financial Review Procedures<\/u>. Because this Amendment has<br \/>\nestablished MPU Product prices for 2011 on a [****] basis, rather than on a<br \/>\n[****] basis, the operational monitoring of the Agreement in 2011 will focus on<br \/>\na process that includes monthly reporting of product shipments, payments, Yield<br \/>\nperformance, [****], and a [****] (of billing versus [****]). FoundryCo also<br \/>\nagrees to support AMD&#8217;s monthly S&amp;OP process, annual business planning<br \/>\nprocess and the long range planning process.<\/p>\n<p>5.2 <u>Additional FoundryCo Audit Rights.<\/u> During 2011, FoundryCo shall<br \/>\nhave audit rights, consistent with Section 8.1(b) of the Agreement, to verify<br \/>\nAMD&#8217;s compliance with its obligations with respect to [****] and [****]<br \/>\ninventories and dispositions thereof.<\/p>\n<p><strong>6.<\/strong> AMENDMENT RELATED TO ALLOCATION OF ADDITIONAL [****]<br \/>\nEXPENSES IN 2011<\/p>\n<p>6.1 <u>Incremental FoundryCo [****] in 2011 for Implementing [****]<br \/>\nTechnology for AMD<\/u>. During 2011 only, AMD may periodically identify and<br \/>\nrequest that FoundryCo invest in additional [****] for the purpose of enhancing<br \/>\nproduct performance or supporting very specific product features for the [****]<br \/>\nMPU Products. In the case where this [****] is unique, unrelated to the<br \/>\nestablished [****], and incremental to the FoundryCo base investment already<br \/>\ndisclosed to AMD as of the Effective Date of this Amendment, AMD acknowledges<br \/>\nfinancial responsibility for the 2011 [****] associated with any such [****]<br \/>\nrequested and approved by AMD. AMD requests for such [****] will be made during<br \/>\nthe monthly meetings between the parties&#8217; [****], and the financial<br \/>\nresponsibility will be captured in the [****] process in 2011. As part of such<br \/>\n[****], the parties will agree in advance on the applicable [****] costs to be<br \/>\npassed through to AMD prior to FoundryCo&#8217;s purchase of such [****]. After 2011,<br \/>\nand for any [****] already incorporated into FoundryCo&#8217;s budget for 2011 and<br \/>\nrequested as an incremental addition by AMD in 2011 as described above, the<br \/>\nterms of the Agreement, rather than the terms of this Section 6 of the<br \/>\nAmendment, shall apply.<\/p>\n<p><strong>7.<\/strong> AMENDMENTS RELATED TO DISPUTE RESOLUTION<\/p>\n<p>7.1 <u>Section 15.11 Governing Law; Dispute Resolution<\/u><\/p>\n<p>Section 15.11(c) of the Agreement shall be amended and restated in its<br \/>\nentirety to read as follows:<\/p>\n<p>(c) Any Dispute not resolved within thirty (30) days of the Dispute Notice<br \/>\nbeing received shall be referred to, and shall be finally and exclusively<br \/>\nresolved by, arbitration under the LCIA Rules then in effect, as amended by this<br \/>\nSection 15.11, which LCIA Rules are deemed to be incorporated by reference into<br \/>\nthis Section 15.11. The seat, or legal place, of the arbitration shall be<br \/>\nLondon, England. The language of the arbitration shall be English. The<\/p>\n<\/p>\n<p align=\"center\">10<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>number of arbitrators shall be three. Each party shall nominate one<br \/>\narbitrator and the two arbitrators nominated by the parties shall, within thirty<br \/>\n(30) days of the appointment of the second arbitrator, agree upon and nominate a<br \/>\nthird arbitrator who shall act as Chairman of the Tribunal. If no agreement is<br \/>\nreached within thirty (30) days, the LCIA Court shall appoint a third arbitrator<br \/>\nto act as Chairman of the Tribunal. It is hereby expressly agreed that if there<br \/>\nis more than one claimant party or more than one respondent party, the claimant<br \/>\nparties shall together nominate one arbitrator and the respondent parties shall<br \/>\ntogether nominate one arbitrator. In the event that a sole claimant or the<br \/>\nclaimant parties, on the one side, or a sole respondent or the respondent<br \/>\nparties, on the other side, fails to nominate its\/their arbitrator, such<br \/>\narbitrator shall be appointed by the LCIA Court. Any award issued by the<br \/>\narbitrators shall be final and binding upon the parties, and, subject to this<br \/>\nSection 15.11, may be entered and enforced in any court of competent<br \/>\njurisdiction by any of the parties. In the event any party subject to such final<br \/>\nand binding award desires to have it confirmed by a final order of a court, the<br \/>\nonly court which may do so shall be a court of competent jurisdiction located in<br \/>\nLondon, England; provided however, that nothing in this sentence shall prejudice<br \/>\nor prevent a party from enforcing the arbitrators&#8217; final and binding award in<br \/>\nany court of competent jurisdiction. The parties hereto acknowledge and agree<br \/>\nthat any breach of the terms of this Agreement could give rise to irreparable<br \/>\nharm for which money damages would not be an adequate remedy. Accordingly, the<br \/>\nparties agree that, prior to the formation of the Tribunal, the parties have the<br \/>\nright to apply exclusively to any court of competent jurisdiction or other<br \/>\njudicial authority located in London, England for interim or conservatory<br \/>\nmeasures, including, without limitation, to compel arbitration (an<br \/>\n&#8220;<strong>Interim Relief Proceeding<\/strong>&#8220;). Furthermore, the parties agree<br \/>\nthat, after the formation of the Tribunal, the arbitrators shall have the sole<br \/>\nand exclusive power to grant temporary, preliminary and permanent relief,<br \/>\nincluding injunctive relief and specific performance, and any then pending<br \/>\nInterim Relief Proceeding shall be discontinued without prejudice to the rights<br \/>\nof any of the parties thereto. Unless otherwise ordered by the arbitrators<br \/>\npursuant to the terms hereof, the arbitrators&#8217; expenses shall be shared equally<br \/>\nby the parties. In furtherance of the foregoing, each of the parties hereto<br \/>\nirrevocably submits to: (i) the exclusive jurisdiction of the courts of England<br \/>\nlocated in London, England in relation to any Interim Relief Proceeding and;<br \/>\n(ii) the non-exclusive jurisdiction of the courts of England located in London,<br \/>\nEngland with respect to the enforcement of any arbitral award rendered in<br \/>\naccordance with this Section 15.11; and, with respect to any such suit, action<br \/>\nor proceeding, waives any objection that it may have to the courts of England<br \/>\nlocated in London, England on the grounds of inconvenient forum. For the<br \/>\navoidance of doubt, where an arbitral tribunal is appointed under this<br \/>\nAgreement, the whole of its award shall be deemed for the purposes of the New<br \/>\nYork Convention on the Recognition and Enforcement of Foreign Arbitral Awards of<br \/>\n1958 to be contemplated by this Agreement, as the case may be (and judgment on<br \/>\nany such award may be entered in accordance with the provisions set forth in<br \/>\nthis Section 15.11).<\/p>\n<\/p>\n<p align=\"center\">11<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p><strong>8.<\/strong> MISCELLANEOUS<\/p>\n<p>Other than as expressly provided in this Amendment, no other amendments are<br \/>\nbeing made to the Agreement, and all other provisions of the Agreement shall<br \/>\nremain in full force and effect in accordance with the terms of the Agreement.\n<\/p>\n<\/p>\n<p align=\"center\">12<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<p>IN WITNESS WHEREOF, the parties have caused this Amendment to the Wafer<br \/>\nSupply Agreement to be executed as of the date first written above by their<br \/>\nrespective officers thereunto duly authorized.<\/p>\n<p align=\"center\">[Signature pages follow]<\/p>\n<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<table width=\"40%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"12%\"><\/td>\n<td width=\"2%\" valign=\"bottom\"><\/td>\n<td width=\"86%\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>ADVANCED MICRO DEVICES, INC.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>By: <u>\/s\/ Thomas J. Seifert <\/u><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>Name:<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\">\n<p>Thomas J. Seifert<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>Title:<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\">\n<p>Senior Vice President, Chief Financial<\/p>\n<p>Officer and Interim Chief Executive Officer<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">Signature Page to Amendment to the Wafer Supply Agreement<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<table width=\"40%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"8%\"><\/td>\n<td width=\"1%\" valign=\"bottom\"><\/td>\n<td width=\"91%\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>GLOBALFOUNDRIES INC.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>By:<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\">\n<p>\/s\/ Chia Song Hwee<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>Name: Chia Song Hwee<\/p>\n<p>Title: Chief Operating Officer<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">Signature Page to Amendment to the Wafer Supply Agreement<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<table width=\"40%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"8%\"><\/td>\n<td width=\"1%\" valign=\"bottom\"><\/td>\n<td width=\"91%\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>GLOBALFOUNDRIES U.S. INC.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<p>By:<\/p>\n<\/td>\n<td valign=\"bottom\"><\/td>\n<td valign=\"bottom\">\n<p>\/s\/ Robert Krakauer<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>Name: Robert Krakauer<\/p>\n<p>Title: CFO<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">Signature Page to Amendment to the Wafer Supply Agreement<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n<hr>\n<table width=\"40%\" cellpadding=\"0\" border=\"0\" cellspacing=\"0\">\n<tbody>\n<tr>\n<td width=\"6%\"><\/td>\n<td width=\"1%\" valign=\"bottom\"><\/td>\n<td width=\"93%\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>GLOBALFOUNDRIES SINGAPORE PTE. LTD.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>By: <u>\/s\/ Robert Krakauer <\/u><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>Name: Robert Krakauer<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" valign=\"top\">\n<p>Title: CFO<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\">Signature Page to Amendment to the Wafer Supply Agreement<\/p>\n<p>[****] = Certain confidential information contained in this document, marked<br \/>\nby brackets, has been omitted and filed separately with the Securities and<br \/>\nExchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of<br \/>\n1934, as amended. Confidential treatment has been requested with respect to the<br \/>\nomitted portions.<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6576],"corporate_contracts_industries":[9512],"corporate_contracts_types":[9613],"class_list":["post-42961","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-advanced-micro-devices-inc","corporate_contracts_industries-technology__semiconductors","corporate_contracts_types-operations"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/42961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=42961"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=42961"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=42961"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=42961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}